Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Molina Healthcare, Inc. (NYSE:MOH – Free Report) by 3.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,578 shares of the company’s stock after acquiring an additional 689 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Molina Healthcare were worth $6,415,000 at the end of the most recent quarter.
Other hedge funds have also recently bought and sold shares of the company. McIlrath & Eck LLC acquired a new stake in Molina Healthcare in the 4th quarter valued at about $34,000. Principal Securities Inc. acquired a new stake in Molina Healthcare in the 4th quarter valued at about $42,000. Access Investment Management LLC acquired a new stake in Molina Healthcare in the 4th quarter valued at about $99,000. Cullen Frost Bankers Inc. raised its position in Molina Healthcare by 22.2% in the 4th quarter. Cullen Frost Bankers Inc. now owns 330 shares of the company’s stock valued at $119,000 after purchasing an additional 60 shares in the last quarter. Finally, Mather Group LLC. acquired a new stake in Molina Healthcare in the 1st quarter valued at about $123,000. Institutional investors and hedge funds own 98.50% of the company’s stock.
Molina Healthcare Stock Performance
NYSE:MOH traded down $1.96 during mid-day trading on Friday, reaching $348.60. 83,449 shares of the stock were exchanged, compared to its average volume of 489,226. The company has a 50 day simple moving average of $319.95 and a 200-day simple moving average of $349.31. The stock has a market capitalization of $20.43 billion, a P/E ratio of 19.02, a P/E/G ratio of 1.20 and a beta of 0.58. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.49. Molina Healthcare, Inc. has a 1 year low of $282.96 and a 1 year high of $423.92.
Analyst Ratings Changes
MOH has been the topic of a number of analyst reports. Robert W. Baird initiated coverage on Molina Healthcare in a research report on Thursday, May 30th. They issued an “outperform” rating and a $405.00 price target on the stock. Deutsche Bank Aktiengesellschaft dropped their price objective on Molina Healthcare from $354.00 to $353.00 and set a “hold” rating on the stock in a report on Monday, July 29th. Stephens reiterated an “equal weight” rating and issued a $320.00 price objective on shares of Molina Healthcare in a report on Thursday, July 25th. Baird R W upgraded Molina Healthcare to a “strong-buy” rating in a report on Thursday, May 30th. Finally, TD Cowen dropped their price objective on Molina Healthcare from $412.00 to $351.00 and set a “buy” rating on the stock in a report on Wednesday, July 24th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating, six have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Molina Healthcare has an average rating of “Moderate Buy” and a consensus target price of $378.00.
Get Our Latest Stock Analysis on Molina Healthcare
Insider Buying and Selling at Molina Healthcare
In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of Molina Healthcare stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total value of $339,210.00. Following the transaction, the director now directly owns 18,025 shares in the company, valued at approximately $6,114,260.25. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other Molina Healthcare news, CAO Maurice Hebert sold 393 shares of Molina Healthcare stock in a transaction that occurred on Thursday, August 15th. The stock was sold at an average price of $346.52, for a total value of $136,182.36. Following the transaction, the chief accounting officer now directly owns 9,473 shares in the company, valued at approximately $3,282,583.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Steven J. Orlando sold 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total value of $339,210.00. Following the completion of the sale, the director now directly owns 18,025 shares of the company’s stock, valued at $6,114,260.25. The disclosure for this sale can be found here. Company insiders own 1.10% of the company’s stock.
Molina Healthcare Company Profile
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Read More
- Five stocks we like better than Molina Healthcare
- What Are Dividend Champions? How to Invest in the Champions
- The Solar Stock Battle: Is Daqo or JinkoSolar Your Next Big Win?
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Are These Chinese Stocks a Buy? Michael Burry’s Top Picks Say Yes
- Conference Calls and Individual Investors
- Five Below Stock Faces Challenges Despite Strong Revenue Growth
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.